Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group operates as a U.S. physician enablement company focused on primary-care centric medical groups, risk-bearing entities and the Privia Platform of technology and service solutions. The company works with medical groups, health plans and health systems to build provider networks and support value-based care.
Company updates commonly cover quarterly and annual operating results, guidance, practice collections, care margin, platform contribution, adjusted EBITDA and provider growth. Recurring developments also include performance in value-based risk arrangements, expansion into new or existing states, material agreements, capital-structure disclosures and governance matters.
ARLINGTON, Va., Jan. 31, 2022 - Privia Health Group, Inc. (Nasdaq: PRVA) will release its fourth quarter and full year financial results for 2021 on March 25, 2022, before the market opens. The press release will be available at ir.priviahealth.com by 7:00 AM ET. Following this, the management will hold a conference call at 8:00 AM ET to discuss the results and future outlook. Interested parties can access the call via a webcast or by phone. The recording will be available for replay shortly after the call.
Privia Health Group, Inc. (Nasdaq: PRVA) has launched three new Accountable Care Organizations (ACOs) in Maryland, Florida, and Tennessee, bringing the total to seven ACOs in its portfolio. Effective January 1, 2022, the Privia Quality Network now includes over 1,900 independent providers serving 168,000+ Medicare beneficiaries. Four ACOs have transitioned to the MSSP Enhanced Track, which entails significant financial risks. In 2020, Privia achieved $86.5 million in shared savings through MSSP, with total savings exceeding $576 million since 2014.
Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Jeffrey S. Sherman as Executive Vice President and Chief Financial Officer, effective immediately. Sherman, who brings significant financial and healthcare experience from previous roles, will oversee finance and accounting activities. Privia Health CEO Shawn Morris emphasized that Sherman’s background will support the company’s growth and long-term value creation. Sherman succeeds David Mountcastle, who is leaving the company after a successful tenure. Privia Health focuses on optimizing physician practices and enhancing patient experiences.
Privia Health Group, Inc. (Nasdaq: PRVA) has announced new capitated arrangements with HealthFirst Health Plan and Humana for its Accountable Care Organizations (ACOs) in Florida and the Mid-Atlantic region. Effective January 1, 2022, these agreements will provide healthcare services to approximately 23,000 Medicare Advantage beneficiaries. The company expects to generate $230 million in practice collections and GAAP revenue from these contracts in 2022, marking a shift from fee-for-service to care management fees for enhanced healthcare services.
ARLINGTON, Va., Jan. 04, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) will participate in the 40th Annual J.P. Morgan Healthcare Conference. The management team is scheduled to present a business overview during a virtual fireside chat on January 10, 2022, at 3:00 PM ET. A webcast, replay, and accompanying slide presentation will be available on their investor relations website.
Privia Health is a technology-driven physician enablement company that collaborates with medical groups and health systems to optimize practices, improve patient experiences, and enhance healthcare quality.
Privia Health Group, Inc. (Nasdaq: PRVA) has priced its public offering of 6,000,000 shares of common stock at $29.00 per share. The offering, initiated by selling stockholders, includes a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this secondary offering, which is set to close on November 23, 2021. The offering is managed by leading financial institutions including Goldman Sachs and J.P. Morgan. Forward-looking statements highlight potential uncertainties regarding the completion of the offering.
Privia Health Group, Inc. (Nasdaq: PRVA) announced a public offering of 6,000,000 shares of common stock by certain selling stockholders, with a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this offering, as costs will be borne by the selling stockholders. Goldman Sachs & Co. LLC and J.P. Morgan are leading the offering. A registration statement has been filed but is not yet effective, and the offering is subject to numerous conditions outside Privia's control.
Privia Health Group, Inc. (PRVA) announced robust third-quarter results with total revenue reaching $251.5 million, a 21.4% increase year-over-year. However, the company reported a net loss of $9.1 million, or $0.09 per share, compared to a profit of $16.7 million in the same period last year. Practice collections rose to $401.5 million, and adjusted EBITDA grew by 51.9% to $13.9 million. The firm entered the California and West Texas markets, raising its full-year 2021 guidance across multiple metrics, signaling strong growth potential ahead.
Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced its participation in three key investor conferences. The events are scheduled for November 10 at the Credit Suisse Healthcare Conference, November 18 at the Canaccord Genuity Digital Health & Services Forum, and December 1 at the Piper Sandler Healthcare Conference. Webcasts and slide presentations will be accessible via the company's investor relations website. Privia Health focuses on enhancing physician practices and patient experiences through advanced technology.
Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.